Suppliers / Ningxia Labschem

Ningxia Labschem

China Updated 9 July 2026

Ningxia Labschem is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Orforglipron US FDA 1
Tirzepatide US FDA 1

Also appears on these molecule pages

Orforglipron API Tirzepatide API

Questions about Ningxia Labschem

Does Ningxia Labschem hold a US DMF or a CEP?
Ningxia Labschem holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Ningxia Labschem make?
2 molecules are on record against Ningxia Labschem, including Orforglipron and Tirzepatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Ningxia Labschem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Sinopep-Allsino Biopharmaceutical shares 1 molecule Allsino Pharmaceutical shares 1 molecule Fujian Genohope Biotech shares 1 molecule El-Peptido (Shanghai) Biopharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability